<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-161800" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vertical Transplacental Infections</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>McCluskey</surname>
            <given-names>James M.</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sato</surname>
            <given-names>Alice I.</given-names>
          </name>
          <aff>UNMC</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>James McCluskey declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alice Sato declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-161800.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>As opposed to horizontal transmission between individuals in a population, vertical transmission of an infectious agent is generally defined as transmission from a pregnant individual&#x000a0;to their fetus. Horizontal transmission during pregnancy is frequently examined based on timing (antenatal, perinatal, or postnatal); more specific considerations involve viral transplacental infections.<xref ref-type="bibr" rid="article-161800.r1">[1]</xref>&#x000a0;Vertical antenatal and in-utero infections&#x000a0;refer to the same general mechanism of infection, although the particular pathophysiologic mechanisms will vary with the infectious agent.&#x000a0;Viral transplacental infections represent a critical category of maternal-fetal health concerns, with the capacity to traverse the placental barrier and adversely affect the developing fetus,&#x000a0;leading to a range of outcomes, from mild disease to severe congenital anomalies or fetal death.</p>
        <p>Infectious agents that can cross the placenta include those historically described by "ToRCHes" (toxoplasmosis, other [hepatitis B virus and syphilis], rubella, cytomegalovirus, and herpes simplex virus). However, <italic toggle="yes">Listeria</italic>, human immunodeficiency virus (HIV), parvovirus B19, varicella-zoster virus, hepatitis C virus, and Zika virus are also known to cause transplacental infections. Each infection can have profound implications for fetal development, with risks varying based on the timing of infection during pregnancy and the specific pathogen involved. See StatPearls' companion references, "&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/17639">Antepartum infections</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22931">HIV in Pregnancy</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/91623">Pregnancy and Viral Hepatitis</ext-link>," for more information on vertically transmitted&#x000a0;infections and associated intrapartum issues.</p>
        <p>Please note that the terms "maternal" and "mother" in this activity refer to the birthing parent and are not meant to exclude other birthing parents.</p>
      </sec>
      <sec id="article-161800.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Maternal infection with the pathogen precedes&#x000a0;fetal acquisition of a transplacental infection. Various transmission routes can result in maternal infection, including sexual contact, consumption of contaminated food, or acquisition from vectors such as&#x000a0;mosquitos or ticks. The mechanisms by which pathogens traverse the placental barrier to affect the developing fetus are not fully understood and differ&#x000a0;between pathogens. Specific placental cell types play a crucial role in this process, including cytotrophoblasts and syncytiotrophoblasts, which act as the primary barrier between the maternal and fetal blood. Extravillous trophoblasts invade maternal tissues, establishing a connection with the maternal immune system.<xref ref-type="bibr" rid="article-161800.r1">[1]</xref>&#x000a0;Please see StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/136052">Immunology at the Maternal-Fetal Interface</ext-link>," for additional information. Generally, after a pregnant individual acquires a primary infection, the pathogen will circulate in the maternal bloodstream and traverse the placenta by infecting several of these interface cell types. Alternatively, in the presence of multiple infectious agents or placental trauma, weakening of the placental barrier may permit maternal and fetal blood&#x000a0;mixing that leads to fetal infection.</p>
        <p>
<bold>Sexually Transmitted Infections</bold>
</p>
        <p>Syphilis is the clinical manifestation of infection with the spirochete&#x000a0;<italic toggle="yes">Treponema pallidum,</italic> and maternal infection can result in fetal infection.<xref ref-type="bibr" rid="article-161800.r2">[2]</xref>&#x000a0;Previously, experts believed that congenital syphilis could only be acquired after the first trimester of pregnancy.<xref ref-type="bibr" rid="article-161800.r3">[3]</xref>&#x000a0;However, it is now widely accepted that maternal syphilis at any stage (primary, secondary, latent, tertiary) carries the potential for congenital syphilis infection throughout the pregnancy. Congenital infection is typically more severe when acquired later in gestation.<xref ref-type="bibr" rid="article-161800.r2">[2]</xref><xref ref-type="bibr" rid="article-161800.r3">[3]</xref><xref ref-type="bibr" rid="article-161800.r4">[4]</xref><xref ref-type="bibr" rid="article-161800.r2">[2]</xref><xref ref-type="bibr" rid="article-161800.r5">[5]</xref>&#x000a0;Please see StatPearls' companion reference,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/29822">"Syphilis,"</ext-link>&#x000a0;for more detailed information on syphilis in nonpregnant individuals. Please see StatPearl's companion reference,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/19869">"Congenital and Maternal Syphilis</ext-link>," for additional details on syphilis in pregnancy.</p>
        <p>Human herpesviruses 1 and 2 (HSV-1, HSV-2) may also be sexually transmitted. Approximately 5% of cases of herpetic infections are transmitted transplacentally. Although transplacental infection typically&#x000a0;results in more severe fetal infections, perinatal acquisition is much more common (85%). Fetal outcomes are thought to be better when infections with alphaherpesvirinae are acquired at an earlier gestational age.<xref ref-type="bibr" rid="article-161800.r6">[6]</xref><xref ref-type="bibr" rid="article-161800.r7">[7]</xref><xref ref-type="bibr" rid="article-161800.r8">[8]</xref>&#x000a0;Please see StatPearl's companion reference,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22931">"</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/19855">Congenital Herpes Simplex</ext-link>," for additional information.&#x000a0;</p>
        <p>Human immunodeficiency viruses 1 and 2&#x000a0;(HIV-1, HIV-2), hepatitis B and C viruses (HBV, HCV), can be maternally acquired via sexual contact, intravenous drug use, or other blood or body fluid exposures. Vertical transmission of HIV is thought to occur primarily in the intrapartum period.<xref ref-type="bibr" rid="article-161800.r9">[9]</xref>&#x000a0;Throughout pregnancy, the risk of fetal acquisition of HIV is correlated with the maternal HIV viral load. Results from a recent study demonstrated no vertical transmission of HIV when the viral load was undetectable at the time of delivery.<xref ref-type="bibr" rid="article-161800.r10">[10]</xref>&#x000a0;The mechanism of in-utero HIV transmission is incompletely understood but estimated to account for 5% to 10% of cases, with suspected mechanisms involving infection of the trophoblasts and transcytosis with HIV in the third trimester.<xref ref-type="bibr" rid="article-161800.r9">[9]</xref>&#x000a0;Please see StatPearl's companion reference <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22931">"HIV in Pregnancy"</ext-link> for additional information.</p>
        <p>A minority of cases of HBV are vertically transmitted by the transplacental route (3.7%).<xref ref-type="bibr" rid="article-161800.r11">[11]</xref>&#x000a0;According to the results from a study, the suspected pathophysiologic mechanisms of viral transmission center around maternal hepatitis B e antigen positivity, threatened preterm labor, and HBV in the villous capillary endothelial cells of the placenta.<xref ref-type="bibr" rid="article-161800.r11">[11]</xref>&#x000a0;The results also demonstrated that transplacental leakage of maternal blood can cause intrauterine infection.<xref ref-type="bibr" rid="article-161800.r11">[11]</xref>&#x000a0;Emerging evidence also shows that HBV infection of maternal peripheral blood mononuclear cells plays a critical role in intrauterine infection.<xref ref-type="bibr" rid="article-161800.r12">[12]</xref>&#x000a0;</p>
        <p>These peripheral mononuclear cells are also involved in the transmission of HCV to the fetus; transmission is also affected by&#x000a0;maternal HCV viremia and coinfection with HIV.<xref ref-type="bibr" rid="article-161800.r13">[13]</xref><xref ref-type="bibr" rid="article-161800.r14">[14]</xref> HCV is unique because intrauterine infection, rather than perinatal transmission, is thought to cause most vertical infections. Furthermore, fetal infection is primarily established in the second or third trimester, though transmission can rarely occur in the first trimester.<xref ref-type="bibr" rid="article-161800.r15">[15]</xref>&#x000a0;Please see StatPearl's companion reference, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/91623">"Pregnancy and Viral Hepatitis,</ext-link>" for additional details on transmission.</p>
        <p>Cytomegalovirus (CMV) is often acquired when individuals are in close contact with others, particularly young children and their body fluids.<xref ref-type="bibr" rid="article-161800.r16">[16]</xref>&#x000a0;CMV is suspected to be transmitted via sexual contact&#x000a0;as well. CMV is very common; the seropositivity of women of childbearing age is estimated to be 86% globally.<xref ref-type="bibr" rid="article-161800.r17">[17]</xref>&#x000a0;Thus, primary CMV infection of the birthing parent during pregnancy is less common, but when it occurs, fetal outcomes are significantly worse compared to secondary maternal infection,<xref ref-type="bibr" rid="article-161800.r18">[18]</xref>&#x000a0;though reinfection with new strains of CMV in seroimmune women can lead to congenital CMV infection.<xref ref-type="bibr" rid="article-161800.r19">[19]</xref> Fetal outcomes are also worse when CMV is acquired early in the pregnancy.<xref ref-type="bibr" rid="article-161800.r20">[20]</xref>&#x000a0;Though CMV is known to infect villous cytotrophoblasts and blood vessels in the villous core, even without actual fetal transmission, this damage to the placenta can also cause intrauterine growth restriction.<xref ref-type="bibr" rid="article-161800.r21">[21]</xref>&#x000a0;Please see StatPearl's companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/19849">Congenital Cytomegalovirus Infection,</ext-link>" for additional information.</p>
        <p>
<bold>Foodborne Illness </bold>
</p>
        <p>The consumption of contaminated food by the pregnant individual is a well-known route for acquiring toxoplasmosis, caused by the parasitic protozoan <italic toggle="yes">Toxoplasma gondii</italic>, and listeriosis, caused by the gram-positive facultative intracellular bacillus, <italic toggle="yes">Listeria monocytogenes</italic>. Pregnant individuals can acquire toxoplasmosis by consuming <italic toggle="yes">T gondii</italic> oocysts in contaminated food, water, or soil (eg, cat litter) or by ingestion of tissue cysts in infected meat.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;Oocysts and tachyzoites are other forms of <italic toggle="yes">T gondii</italic>, the latter of which is the mobile form known to infect a fetus transplacentally.<xref ref-type="bibr" rid="article-161800.r23">[23]</xref>&#x000a0;Other sources of congenital <italic toggle="yes">T gondii </italic>infection include reactivation of latent disease in a pregnant individual or reinfection with a different, more virulent strain.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;Please see StatPearl's companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/95334">Toxoplasmosis</ext-link>" and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/19872">Congenital Toxoplasmosis</ext-link>," for further discussion.</p>
        <p>Listeriosis can be contracted from eating foods made with unpasteurized milk, deli meats, and ready-to-eat food that has not been properly cooked or is contaminated after cooking.<xref ref-type="bibr" rid="article-161800.r24">[24]</xref><xref ref-type="bibr" rid="article-161800.r25">[25]</xref>&#x000a0;<italic toggle="yes">L monocytogenes</italic>&#x000a0;is found in farms and on food processing equipment, and survives and grows in cold, high salt, and low pH conditions.<xref ref-type="bibr" rid="article-161800.r26">[26]</xref> It has specific tropism for the placenta, with significantly increased fetal death occurring when infection is established before 29 weeks gestation.<xref ref-type="bibr" rid="article-161800.r24">[24]</xref><xref ref-type="bibr" rid="article-161800.r27">[27]</xref>&#x000a0;</p>
        <p>
<bold>Illness Acquired Via Airborne Transmission</bold>
</p>
        <p>Human parvovirus B19&#x000a0;(B19V) is the etiologic agent of the common childhood disease erythema infectiosum and is spread via respiratory droplets. Infection with B19V most frequently occurs among those with repeated contact with school-aged children.<xref ref-type="bibr" rid="article-161800.r28">[28]</xref><xref ref-type="bibr" rid="article-161800.r29">[29]</xref>&#x000a0;Often the infected pregnant individual is asymptomatic. B19V infection of endothelial cells within placental villi plays the primary role in transplacental infection of the fetus.<xref ref-type="bibr" rid="article-161800.r30">[30]</xref>&#x000a0;When parvovirus B19 fetal infection occurs before 20 weeks gestation, the infection has been shown to disproportionally result in the most severe complications, including nonimmune hydrops fetalis and fetal death.<xref ref-type="bibr" rid="article-161800.r29">[29]</xref>&#x000a0;</p>
        <p>The rubella virus also spreads via respiratory droplets. The overall incidence of rubella is low due to widespread vaccination, with rubella elimination verified in 98 (51%) of 194 countries by 2022.<xref ref-type="bibr" rid="article-161800.r31">[31]</xref> Due to the rarity of fetal rubella&#x000a0;infection, the pathophysiologic mechanism is unclear; emboli of necrotized endothelial cells from the infected chorion are suspected.<xref ref-type="bibr" rid="article-161800.r32">[32]</xref>&#x000a0;If a pregnant individual acquires rubella within the first 12 weeks of gestation, severe consequences for the developing fetus can result. Maternal infection in the second and third trimesters carries significantly less risk to the fetus.<xref ref-type="bibr" rid="article-161800.r33">[33]</xref>&#x000a0;Please see StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/19868">Congenital Rubella Syndrome,</ext-link>" for additional information.</p>
        <p>Varicella-zoster virus (VZV), or human herpesvirus 3, is the etiologic agent of chickenpox; reactivation of VZV causes shingles. VZV primarily spreads through respiratory droplets or direct contact with blister fluid. Primary infection with VZV during pregnancy is now rare secondary to vaccination; individuals of childbearing age have a high seroprevalence, especially in the United States.<xref ref-type="bibr" rid="article-161800.r7">[7]</xref><xref ref-type="bibr" rid="article-161800.r34">[34]</xref>&#x000a0;Primary VZV infection during pregnancy,&#x000a0;rather than secondary infection or reactivation, is believed to lead to congenital varicella syndrome.<xref ref-type="bibr" rid="article-161800.r35">[35]</xref>&#x000a0;Vertical transmission of VZV is thought to be transplacental; the mechanism is unknown. Primary acquisition of VZV by pregnant individuals before an estimated gestational age of 20 weeks poses the highest risk of subsequent congenital varicella syndrome (0.91%). Congenital&#x000a0;varicella syndrome has been reported following maternal primary varicella infection between an estimated gestational age of 20 and 28 weeks and recently as late as 36 weeks.<xref ref-type="bibr" rid="article-161800.r36">[36]</xref><xref ref-type="bibr" rid="article-161800.r37">[37]</xref>&#x000a0;Please see StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/130914">Congenital Varicella Syndrome</ext-link>,"&#x000a0;for additional information.</p>
        <p>
<bold>Vector-Borne Disease</bold>
</p>
        <p>Zika virus (ZIKV) is a vector-borne disease with maternal-fetal relevance. ZIKV is transmitted primarily through bites from infected <italic toggle="yes">Aedes</italic> mosquitoes and through sexual contact with infected individuals, blood transfusions, and contact with bodily fluids. Once a pregnant individual is infected, ZIKV is suspected to infect trophoblasts, cross the placental and blood-brain barriers, and infect brain endothelial cells.<xref ref-type="bibr" rid="article-161800.r38">[38]</xref>&#x000a0;In addition, ZIKV appears to disrupt the permeability of tight junctions, permitting paracellular transplacental but not blood-brain barrier transmission.<xref ref-type="bibr" rid="article-161800.r38">[38]</xref></p>
      </sec>
      <sec id="article-161800.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Not all epidemiologic studies separate infections acquired transplacentally from infections that may be acquired perinatally. The following discussion focuses on the epidemiology of vertically transmitted infectious agents thought to be acquired primarily by the transplacental route.</p>
        <p>
<bold>Syphilis</bold>
</p>
        <p>Incidence rates of congenital syphilis are highest in low- and middle-income countries, while in high-income countries, cases have resurged over the past decade.<xref ref-type="bibr" rid="article-161800.r39">[39]</xref>&#x000a0;Between 2012 and 2016, 1120 cases of congenital syphilis per 100,000 live births were diagnosed in Africa, 19 cases per 100,000 were diagnosed in Europe, 339 per 100,000 were diagnosed in the Americas, and 640 per 100,000 were identified in the Eastern Mediterranean region.<xref ref-type="bibr" rid="article-161800.r39">[39]</xref>&#x000a0;In 2016, the global incidence of congenital syphilis was estimated to be 473 cases per 100,000 live births; this was nearly unchanged in 2020, estimated at 425 cases per 100,000.<xref ref-type="bibr" rid="article-161800.r40">[40]</xref><xref ref-type="bibr" rid="article-161800.r39">[39]</xref> In the United States, the absolute number of congenital syphilis cases increased from 941 in 2017 to 2677 in 2021. This data likely underestimates the true disease burden due to unrecognized or asymptomatic infection, among other reasons.<xref ref-type="bibr" rid="article-161800.r39">[39]</xref>&#x000a0;The reasons behind increasing case numbers are multifactorial, but decreased testing during the COVID-19 pandemic plays a key role.<xref ref-type="bibr" rid="article-161800.r41">[41]</xref></p>
        <p>
<bold>Hepatitis C Virus</bold>
</p>
        <p>Geographically, the burden of HCV infection is similar to syphilis, with a pooled prevalence of HCV among pregnant women in low-income countries (2.7%) higher than that of lower-middle-income countries (2.3%); both are higher than the global&#x000a0;prevalence of 1.0%. However, unlike syphilis, the prevalence of HCV has decreased over time, with a prevalence of 0.8% reported from 2001&#x000a0;to 2010&#x000a0;and&#x000a0;0.5% from 2011 to 2020. Of children born to HCV antibody-positive and ribonucleic acid-positive women, about 5.8% go on to develop HCV infection, while about 10.8% develop HCV when they are born to mothers who are dual HCV- and HIV-positive.<xref ref-type="bibr" rid="article-161800.r14">[14]</xref></p>
        <p>
<bold>Toxoplasmosis</bold>
</p>
        <p>The most robust epidemiologic data for congenital toxoplasmosis comes from France and Brazil, where surveillance programs exist for pregnant individuals. In France, 2 to 3 infants per 10,000 live births were estimated to be infected, while in Brazil, this number is estimated to be between 1 in 622 to 1 in 770 live births.<xref ref-type="bibr" rid="article-161800.r42">[42]</xref>&#x000a0;In the United States, the prevalence of <italic toggle="yes">T gondii</italic>&#x000a0;in women of childbearing age has decreased from 15% between 1988 and 1994 to 9% between 2009 and 2010.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;Approximately 91% of these women in the United States are at risk of primary infection with <italic toggle="yes">T gondii</italic>; in France, this number approximates 70%.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref><xref ref-type="bibr" rid="article-161800.r43">[43]</xref> Not all primary infections result in congenital toxoplasmosis. The risk of transmission increases significantly with infections later in pregnancy, estimated at 15%, 44%, and 71% for seroconversion occurring at 13, 26, and 37 weeks gestation, respectively.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref></p>
        <p>
<bold>Listeriosis</bold>
</p>
        <p>The incidence of listeriosis is less well-defined, and many cases likely go unreported due to a lack of severe symptoms or testing. However, a recent epidemiologic study in the United States demonstrated that the average incidence rate of pregnancy-associated listeriosis between 2004 and 2009 was 4.5 cases per 100,000.<xref ref-type="bibr" rid="article-161800.r44">[44]</xref>&#x000a0;In this study, the consumption of Mexican-style soft cheeses emerged as a significant risk factor. Subsequently, Hispanic ethnicity was also identified as a notable risk factor. This same United States-based study estimated 1 listeriosis infection in every 8000 pregnancies within the Hispanic population, and nearly 1 in 3 of these cases resulted in neonatal death or fetal loss.<xref ref-type="bibr" rid="article-161800.r44">[44]</xref></p>
        <p>
<bold>Cytomegalovirus</bold>
</p>
        <p>Respiratory-acquired illnesses are common, and the epidemiology of congenital CMV infection reflects this. A 2007 meta-analysis reviewing the epidemiology of CMV estimated the combined birth prevalence of congenital CMV to be 0.64% when assessed in all live-born infants.<xref ref-type="bibr" rid="article-161800.r16">[16]</xref></p>
        <p>
<bold>Parvovirus B19</bold>
</p>
        <p>Infection with B19V occurs globally, and the susceptibility of women of childbearing age ranges from 26% to 44%, with the risk of acquiring B19V during pregnancy estimated to be 1% to 2% during endemic periods and 10% during epidemic periods.<xref ref-type="bibr" rid="article-161800.r45">[45]</xref>&#x000a0;Seronegative pregnant&#x000a0;patients who are initially exposed to the virus are estimated to transmit the infection to the fetus in approximately 17% to 35% of cases.<xref ref-type="bibr" rid="article-161800.r45">[45]</xref></p>
        <p>
<bold>Rubella and Varicella</bold>
</p>
        <p>The epidemiology of congenital rubella syndrome and congenital varicella syndrome has changed dramatically with widespread vaccine availability. Before the introduction of rubella vaccines, congenital rubella syndrome incidence ranged between 0.1 to 0.2 cases per 1000 live births and 0.8 to 4.0 cases per 1000 during epidemic periods.<xref ref-type="bibr" rid="article-161800.r46">[46]</xref>&#x000a0;Since the vaccine's introduction, the incidence has decreased to less than 1 case per 100,000 live births.<xref ref-type="bibr" rid="article-161800.r47">[47]</xref>&#x000a0;However, as of 2020, the rubella vaccine has reached only 70% of the global population, and the incidence in vaccine-limited areas remains elevated at approximately 64 per 100,000 live births.<xref ref-type="bibr" rid="article-161800.r47">[47]</xref><xref ref-type="bibr" rid="article-161800.r48">[48]</xref> Congenital varicella syndrome appears to be rare overall; results from a recent literature review found 130 cases of congenital varicella syndrome reported from 1947 to 2013.<xref ref-type="bibr" rid="article-161800.r37">[37]</xref>&#x000a0;The authors estimated the incidence of congenital varicella syndrome to be 0.59% and 0.84% for women infected with varicella virus throughout pregnancy and in the first 20 weeks of gestation, respectively.<xref ref-type="bibr" rid="article-161800.r37">[37]</xref></p>
        <p>
<bold>Zika Virus</bold>
</p>
        <p>ZIKV stands out epidemiologically from other infectious agents because its reach is geographically bound. Before 2007, ZIKV cases were reported in Africa and Southeast Asia. In 2007, a ZIKV outbreak was reported in Yap State, Federated States of Micronesia, followed by a 2013 outbreak in French Polynesia. The virus subsequently spread to other Pacific islands and, in 2015, to Brazil and the Americas.<xref ref-type="bibr" rid="article-161800.r49">[49]</xref>&#x000a0;Each of these outbreaks had varying incidence rates, and vertical transmission was suspected to occur in approximately 20% to 30% of cases, irrespective of the trimester when maternal infection occurred.<xref ref-type="bibr" rid="article-161800.r50">[50]</xref>&#x000a0;A report of the 2015 Brazil outbreak had 5909 suspected cases of congenital ZIKV syndrome; of these, only 1501 underwent complete investigation, and 76 were confirmed.<xref ref-type="bibr" rid="article-161800.r51">[51]</xref></p>
      </sec>
      <sec id="article-161800.s4" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Vertical transplacental infections may cause symptoms or signs in pregnant individuals, fetuses, or neonates. Fetal signs and symptoms are typically identified via antenatal ultrasonography. The most crucial components of the medical history for all of these situations require a comprehensive interview of the pregnant or recently postpartum individual. Inquiries should focus on the risk factors for each etiologic agent, including a thorough sexual, occupational, dietary, travel, and substance use history.</p>
        <p>If the pregnant individual is symptomatic, then a thorough physical examination should be performed in conjunction with fetal ultrasonography. Nonspecific ultrasonographic&#x000a0;findings that may raise concern for vertical transplacental infections include but are not limited to intracranial, abdominal, and liver calcifications; microcephaly; cardiac malformations; limb deformities; hepatosplenomegaly; echogenic bowel or kidneys; ascites; cerebral ventriculomegaly; hydrops fetalis; and growth restriction.<xref ref-type="bibr" rid="article-161800.r7">[7]</xref><xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Nonspecific physical findings in neonates that may raise concern for vertical transplacental infections include but are not limited to fever, sepsis, low birth weight, microcephaly, cataracts, maculopapular rash, purpuric skin lesions or "blueberry muffin" lesions, petechiae, jaundice, hepatosplenomegaly, and lymphadenopathy.</p>
        <p>Some fetal and neonatal findings are more characteristic of specific infections. Early-onset sepsis is more typical of listeriosis.<xref ref-type="bibr" rid="article-161800.r53">[53]</xref>&#x000a0;Microcephaly should prompt suspicion of congenital rubella syndrome or infection with CMV, human herpesvirus 1 or 2,&#x000a0;<italic toggle="yes">T gondii</italic>, and ZIKV.<xref ref-type="bibr" rid="article-161800.r54">[54]</xref>&#x000a0;Ocular abnormalities (eg, cataracts) may indicate congenital rubella or varicella syndromes or infection with CMV or <italic toggle="yes">T gondii</italic>.<xref ref-type="bibr" rid="article-161800.r7">[7]</xref>&#x000a0;Sensorineural hearing impairment, heart defects, and congenital cataracts are the most commonly presenting symptoms of congenital rubella syndrome.<xref ref-type="bibr" rid="article-161800.r48">[48]</xref>&#x000a0;Microphthalmos and certain limb abnormalities (eg, hypoplastic lower extremities) are commonly seen in congenital varicella syndrome.<xref ref-type="bibr" rid="article-161800.r55">[55]</xref>&#x000a0;Low birth weight or being small for gestational age are commonly associated with transplacental infections and are nonspecific.<xref ref-type="bibr" rid="article-161800.r7">[7]</xref>&#x000a0;Hepatosplenomegaly is also common with transplacental infections and is nonspecific.<xref ref-type="bibr" rid="article-161800.r54">[54]</xref>&#x000a0;</p>
        <p>Neonates&#x000a0;with CMV are most likely to have several abnormal findings (91%); an isolated finding is seen in only 8% of infants.<xref ref-type="bibr" rid="article-161800.r56">[56]</xref>&#x000a0;Another study's results showed the most common finding for infants with CMV was petechiae (74%), though hydrocephalus and intracranial calcifications are typically described.<xref ref-type="bibr" rid="article-161800.r56">[56]</xref>&#x000a0;The blueberry muffin rash classically raises concern for most ToRCHes infections; however, a true blueberry muffin-appearing rash is thought to be due to extramedullary erythropoiesis occurring in the skin, and rubella and CMV are the only infectious agents that have dermal erythropoiesis&#x000a0;documented by skin biopsy.<xref ref-type="bibr" rid="article-161800.r57">[57]</xref></p>
      </sec>
      <sec id="article-161800.s5" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosing a vertical transplacental infection may require evaluating a pregnant person, neonate, or both. Standard prenatal protocols in the United States recommend routine screening for many infections capable of transplacental infection, including HIV, HBV, HCV, and syphilis, in addition to rubella and varicella immune status. In high-risk areas, <italic toggle="yes">T gondii </italic>serology is also recommended<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-161800.r58">[58]</xref><xref ref-type="bibr" rid="article-161800.r59">[59]</xref><xref ref-type="bibr" rid="article-161800.r60">[60]</xref><xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;These evaluations should be repeated if new risk factors develop during pregnancy. Interestingly, beyond this screening, the use of the ToRCHes screening panel is falling out of favor.<xref ref-type="bibr" rid="article-161800.r61">[61]</xref><xref ref-type="bibr" rid="article-161800.r62">[62]</xref>&#x000a0;Risk factors primarily drive maternal and&#x000a0;neonatal evaluation.</p>
        <p>
<bold>Syphilis</bold>
</p>
        <p>Infants born to mothers with a positive rapid plasma reagin (RPR) at any point during pregnancy should also undergo RPR testing at birth; results should be compared to the maternal titer at that time. Infants are subsequently risk-stratified by physical examination findings, neonatal and maternal RPR titers, and maternal treatment history to determine if further evaluation is indicated. Maternal treatment must be fully documented, with timing, dosing, and antibiotic used reviewed in detail. Penicillin G is the only antibiotic treatment during pregnancy known to prevent congenital syphilis.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref> Further fetal evaluation may include a complete blood count, lumbar puncture, or bone radiographs to evaluate for osteolytic lesions.<xref ref-type="bibr" rid="article-161800.r64">[64]</xref></p>
        <p>
<bold>Hepatitis C Virus</bold>
</p>
        <p>Infant HCV evaluation should include an HCV antibody test at approximately 18 months of age or an HCV RNA polymerase chain reaction (PCR) test&#x000a0;between 1 and 2 months of age.<xref ref-type="bibr" rid="article-161800.r65">[65]</xref> If HCV infection is suspected, serial monitoring of liver function with transaminases and coagulation studies is reasonable.</p>
        <p>
<bold>Toxoplasmosis</bold>
</p>
        <p>The evaluation for <italic toggle="yes">T gondii </italic>infection in a pregnant individual should include IgG and IgM serology, followed by IgG avidity testing if appropriate.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Fetal <italic toggle="yes">T gondii </italic>infection can be confirmed by polymerase chain reaction (PCR) of amniotic fluid after 18 weeks gestation, and the fetus should subsequently be followed by ultrasound at least monthly for the remainder of gestation.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref><xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Newborn <italic toggle="yes">T gondii </italic>infection can be confirmed via&#x000a0;<italic toggle="yes">T gondii </italic>immunoglobulin (Ig)<italic toggle="yes">&#x000a0;</italic>IgG, IgM, and IgA titers, and if the suspicion is high, blood, urine, or cerebral spinal fluid PCR should also be obtained.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;Further investigation for end-organ damage and to ensure treatment tolerance may include blood counts, liver and kidney function testing, screening for glucose-6-phosphatase dehydrogenase deficiency, head ultrasonography or computed tomography, eye examination, and hearing evaluation.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref></p>
        <p>
<bold>Listeriosis</bold>
</p>
        <p>Fever in a pregnant individual or early-onset sepsis in an infant should prompt evaluation for listeriosis with studies including blood culture, placental culture, or&#x000a0;cerebrospinal fluid evaluation.<xref ref-type="bibr" rid="article-161800.r53">[53]</xref><xref ref-type="bibr" rid="article-161800.r66">[66]</xref></p>
        <p>
<bold>Cytomegalovirus</bold>
</p>
        <p>Abnormal findings on fetal ultrasound usually prompt CMV evaluation using IgG avidity assays combined with IgM titers or serial serologic assays.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;These assays are considered positive if seroconversion or a greater than or equal to a &#x02014;4-fold increase in anti-CMV IgG titers is identified.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Congenital CMV can be detected in amniotic fluid by culture or PCR at least 6 weeks after maternal infection and after 21 weeks of gestation.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref><xref ref-type="bibr" rid="article-161800.r67">[67]</xref> The diagnosis of congenital cytomegalovirus is made within 21 days of birth by PCR testing of saliva (preferred), urine, or dried blood on Guthrie cards.<xref ref-type="bibr" rid="article-161800.r67">[67]</xref><xref ref-type="bibr" rid="article-161800.r68">[68]</xref>&#x000a0;Further investigation for end-organ damage includes blood counts, liver, kidney, and coagulation testing, head ultrasonography, eye examination, and, most importantly, hearing evaluation.</p>
        <p>
<bold>Parvovirus B19</bold>
</p>
        <p>Pregnant individuals exposed to B19V should have serologic IgG and IgM evaluations performed immediately after exposure.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Those who are IgG positive and IgM negative likely have immunity from previous exposure and are not at risk of transplacental transmission.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Meanwhile, those who are IgM positive, regardless of IgG status, should be monitored for fetal infection and hydrops fetalis.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Those who are negative for IgG and IgM are susceptible to infection, and testing should be repeated in 4 weeks.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;If repeat testing demonstrates positive IgG or IgM, these individuals should be monitored for potential fetal infection and anemia by serial ultrasonography with Doppler of the middle cerebral artery or B19V PCR in amniotic fluid.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;After birth, serum B19V PCR can be obtained in neonates to confirm the diagnosis.</p>
        <p>
<bold>Rubella Virus</bold>
</p>
        <p>All pregnant individuals should undergo a rubella IgG test at the earliest prenatal visit.<xref ref-type="bibr" rid="article-161800.r69">[69]</xref>&#x000a0;Positive rubella IgG antibody testing indicates immunity.<xref ref-type="bibr" rid="article-161800.r69">[69]</xref>&#x000a0;Pregnant individuals who are IgG-negative and therefore susceptible to rubella infection should be monitored for signs or symptoms of rubella infection and vaccinated postpartum.<xref ref-type="bibr" rid="article-161800.r69">[69]</xref>&#x000a0;A rubella IgM&#x000a0;antibody titer can be used to diagnose acute or recent rubella infection in pregnant individuals.<xref ref-type="bibr" rid="article-161800.r69">[69]</xref>&#x000a0;The laboratory evaluation for congenital rubella syndrome in a neonate can&#x000a0;comprise&#x000a0;rubella-specific IgM antibodies performed within 2 months of birth, rubella-specific IgG antibodies persisting at a high concentration or long duration after birth, defined as the titer not decreasing to a 2-fold dilution per month, or isolation of rubella by viral culture or detection of viral ribonucleic acid (RNA) from the nasopharynx, urine, cerebrospinal fluid (CSF), or serum or cord blood.<xref ref-type="bibr" rid="article-161800.r70">[70]</xref>&#x000a0;A further investigation of the possible complications or diagnostic confirmation of congenital rubella syndrome includes reviewing documentation of maternal rubella immunity, physical examination assessing for the aforementioned features, blood counts, liver function and bilirubin testing, CSF evaluation, echocardiography, radiography of long bones, ophthalmologic evaluation, audiology evaluation, and neuroimaging by ultrasound or computed tomography.<xref ref-type="bibr" rid="article-161800.r69">[69]</xref><xref ref-type="bibr" rid="article-161800.r70">[70]</xref></p>
        <p>
<bold>Varicella Virus</bold>
</p>
        <p>Acute varicella viral skin infection, or chickenpox&#x02014;in an individual of any age, pregnant or otherwise&#x02014;is usually diagnosed clinically based on the finding of a classic pruritic, vesicular rash. However, if laboratory diagnosis is desired, a sample&#x000a0;may be taken from an unroofed lesion for qualitative varicella PCR. Subsequently, fetal varicella infection can be evaluated by ultrasonography after documented acute maternal infection.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Congenital varicella syndrome criteria include the appearance of chickenpox during pregnancy, the presence of congenital skin lesions in a dermatomal distribution or neurologic defects, eye disease, limb hypoplasia, proof of intrauterine VZV infection by detection of viral deoxyribonucleic acid in the fetus, the presence of VZV-specific IgM or IgG beyond 7 months of age, and the appearance of zoster during early infancy.<xref ref-type="bibr" rid="article-161800.r37">[37]</xref><xref ref-type="bibr" rid="article-161800.r71">[71]</xref></p>
        <p>
<bold>Zika Virus</bold>
</p>
        <p>In pregnant individuals with suspected ZKIV infection or suspicious fetal ultrasound findings, specific IgM and nucleic acid testing is recommended as soon as possible, up to 12 weeks after symptom onset.<xref ref-type="bibr" rid="article-161800.r72">[72]</xref>&#x000a0;If ZKIV infection is confirmed, serial fetal ultrasonographic evaluations should be obtained to monitor for the effects on the fetus.<xref ref-type="bibr" rid="article-161800.r72">[72]</xref>&#x000a0;Amniocentesis is not considered beneficial for diagnostic confirmation.<xref ref-type="bibr" rid="article-161800.r72">[72]</xref><xref ref-type="bibr" rid="article-161800.r73">[73]</xref><xref ref-type="bibr" rid="article-161800.r74">[74]</xref>&#x000a0;PCR and IgM enzyme-linked immunosorbent assay testing can be performed on serum and urine for neonatal testing at birth.<xref ref-type="bibr" rid="article-161800.r75">[75]</xref>&#x000a0;PCR testing for ZKIV ribonucleic acid and IgM can also be performed on CSF; cord blood studies are not recommended.<xref ref-type="bibr" rid="article-161800.r75">[75]</xref>&#x000a0;If the diagnosis is highly suspicious, further infant evaluation should include a head ultrasound, thorough eye examination, and hearing screen.<xref ref-type="bibr" rid="article-161800.r75">[75]</xref></p>
      </sec>
      <sec id="article-161800.s6" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of transplacental infections depends on the timing of the diagnosis (eg, antenatal or postpartum). Additionally, the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States recommendations are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicalinfo.hiv.gov/en/guidelines">https://clinicalinfo.hiv.gov/en/guidelines</ext-link>.<xref ref-type="bibr" rid="article-161800.r59">[59]</xref><xref ref-type="bibr" rid="article-161800.r76">[76]</xref><xref ref-type="bibr" rid="article-161800.r77">[77]</xref><xref ref-type="bibr" rid="article-161800.r78">[78]</xref></p>
        <p>
<bold>Syphilis</bold>
</p>
        <p>Penicillin G is the mainstay of treatment for syphilis in all persons, including pregnant individuals, neonates, and infants.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;For pregnant individuals, the recommended penicillin G regimen is based on the stage of the disease.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;Intramuscular (IM) penicillin G is recommended in all cases except for neurosyphilis, where intravenous (IV) treatment is needed.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;For primary, secondary, and early latent syphilis, a single IM dose of 2.4 million units of penicillin G is recommended.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;For late, latent, and tertiary syphilis, 7.2 million units total, administered in 3 divided doses of 2.4 million&#x000a0;units IM weekly, is recommended.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;Finally, for neurosyphilis, including ocular and otic, 18 to 24 million units daily, administered as 3 to 4 million&#x000a0;units IV every 4 hours or a continuous infusion for 10 to 14 days, is recommended.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;Penicillin G is the only antibiotic treatment during pregnancy known to prevent congenital syphilis; desensitization should be undertaken in the case of a penicillin allergy.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;</p>
        <p>For infants, IV penicillin G with age-based dosing for 10 days is preferred. The standard dose according to age is 50,000&#x000a0;units/kg every 12 hours for neonates aged 0 to 7 days, followed by 50,000&#x000a0;units/kg every 8 hours starting at 8 days of age, and another adjustment after 1 month.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref>&#x000a0;If treatment is missed for a day, the course should be restarted, and previously administered antibiotics&#x000a0;do not count toward the total course duration.<xref ref-type="bibr" rid="article-161800.r63">[63]</xref></p>
        <p>
<bold>Hepatitis C Virus</bold>
</p>
        <p>No treatment options currently exist for HCV diagnosed during pregnancy.<xref ref-type="bibr" rid="article-161800.r59">[59]</xref> However, after birth, if the infant is also diagnosed with HCV based on the screening recommendations, treatment should be delayed until the child is 3 years or older. The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America HCV recommendations are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.hcvguidelines.org/">https://www.hcvguidelines.org</ext-link>.</p>
        <p>
<bold>Toxoplasmosis</bold>
</p>
        <p>In pregnant&#x000a0;patients diagnosed with toxoplasmosis before 18 weeks gestation, treatment with spiramycin is recommended.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;If the fetus has signs of congenital toxoplasmosis, either by amniotic fluid PCR or ultrasonographic findings, treatment should be changed from spiramycin to pyrimethamine, sulfadiazine, and folinic acid for the remainder of the pregnancy.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;For fetuses without toxoplasmosis signs, spiramycin should be continued throughout gestation. For pregnant individuals diagnosed with toxoplasmosis after 18 weeks gestation, pyrimethamine, sulfadiazine, and folinic acid are preferred initially.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;If the fetus does not develop congenital toxoplasmosis as determined by amniotic fluid PCR or ultrasound findings, the pregnant individual can either continue the regimen for the remainder of pregnancy or be switched to spiramycin.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;</p>
        <p>Treatment for neonatal toxoplasmosis is more ill-defined. Some treatment protocols for neonates include pyrimethamine, sulfadiazine, and folinic acid treatment for the first 3 weeks of life, followed by a change to spiramycin until 2 months of age, and then returning to the pyrimethamine, sulfadiazine, and folinic acid regimen until 12 months of age.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;Conversely, some treatment protocols continue the same regimens until 24 months of age, and others forgo spiramycin.<xref ref-type="bibr" rid="article-161800.r22">[22]</xref>&#x000a0;Consultation with a pediatric infectious disease specialist and a retinal exam by an experienced ophthalmologist is recommended.</p>
        <p>
<bold>Listeriosis</bold>
</p>
        <p>If listeriosis is suspected or confirmed in a pregnant individual, the preferred treatment is a minimum of 14 days of high-dose intravenous ampicillin, with or without gentamicin.<xref ref-type="bibr" rid="article-161800.r66">[66]</xref>&#x000a0;For patients&#x000a0;with a penicillin allergy, trimethoprim with sulfamethoxazole is preferred.<xref ref-type="bibr" rid="article-161800.r66">[66]</xref>&#x000a0;Similar regimens are recommended for infants.</p>
        <p>
<bold>Cytomegalovirus</bold>
</p>
        <p>Currently, no treatment is consistently advised for suspected or confirmed CMV infection in a pregnant individual or their fetus.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Valacyclovir does have mounting evidence supporting its use in this circumstance, but is only currently used in research settings.<xref ref-type="bibr" rid="article-161800.r67">[67]</xref><xref ref-type="bibr" rid="article-161800.r79">[79]</xref><xref ref-type="bibr" rid="article-161800.r80">[80]</xref>&#x000a0;However, the use of valacyclovir is routinely recommended for moderate to severe illness in the postpartum period.<xref ref-type="bibr" rid="article-161800.r67">[67]</xref>&#x000a0;Typically, treatment is recommended for at least 6 months, and antiviral therapy is not routinely recommended for asymptomatic or mild disease.<xref ref-type="bibr" rid="article-161800.r67">[67]</xref>&#x000a0;For infants with isolated sensorineural hearing loss and diagnosed congenital CMV, valacyclovir started within the first 13 weeks following birth (ie, up to 12 weeks 6 days) can be offered for a limited 6-week treatment course according to the 2024 American Academy of Pediatrics Committee on Infectious Diseases,<xref ref-type="bibr" rid="article-161800.r67">[67]</xref><xref ref-type="bibr" rid="article-161800.r81">[81]</xref>&#x000a0;though this remains an area of study and controversy. Consultation with a pediatric infectious disease specialist is recommended.</p>
        <p>
<bold>Parvovirus B19</bold>
</p>
        <p>Monitoring for hydrops fetalis and fetal anemia is recommended when managing suspected or confirmed maternal or fetal&#x000a0;B19V infection. Fetal hematocrit obtained by blood sampling is used to monitor and determine the need for fetal transfusion.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Outside of these interventions, no B19V-specific antivirals or supportive measures are recommended.</p>
        <p>
<bold>Rubella Virus</bold>
</p>
        <p>No specific antiviral treatments are available to treat rubella infection at any age.<xref ref-type="bibr" rid="article-161800.r48">[48]</xref>&#x000a0;The management of congenital rubella syndrome targets&#x000a0;prevention with rubella vaccination and managing complications.</p>
        <p>
<bold>Varicella Virus</bold>
</p>
        <p>If varicella infection is suspected or confirmed in a pregnant individual or their fetus, oral acyclovir, when started within 24 hours of developing the varicella rash, can decrease the duration of symptoms and the number of lesions that may develop.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Intravenous acyclovir may also reduce maternal complications associated with varicella pneumonia. However, neither route of acyclovir seems to have a&#x000a0;significant effect on reducing the fetal effects of congenital varicella syndrome.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;Pregnant&#x000a0;patients exposed to varicella infection without evidence of immunity should be offered varicella immunoglobulin (VZIG) within 10 days of exposure.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref><xref ref-type="bibr" rid="article-161800.r82">[82]</xref>&#x000a0;Despite sparse evidence, VZIG is believed to reduce the incidence of congenital varicella syndrome.<xref ref-type="bibr" rid="article-161800.r52">[52]</xref>&#x000a0;After birth, acyclovir and VZIG can be used to reduce perinatal transmission opportunities.</p>
        <p>
<bold>Zika Virus</bold>
</p>
        <p>No specific antiviral treatments are available for ZIKV infection at any age.<xref ref-type="bibr" rid="article-161800.r83">[83]</xref>&#x000a0;The management of congenital ZIKV infection focuses on preventing exposures and managing infection complications.</p>
      </sec>
      <sec id="article-161800.s7" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of a pregnant individual, fetus, or neonate with the signs and symptoms consistent with a&#x000a0;transplacental infection is broad. Transplacental infections have a vast array of presentations and may mimic many other conditions. Diagnoses to consider include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Autoimmune diseases leading to placental insufficiency and other complications</p>
          </list-item>
          <list-item>
            <p>Chromosomal abnormalities, such as Trisomy 21, Trisomy 18, and Trisomy 13, with growth restriction and structural anomalies</p>
          </list-item>
          <list-item>
            <p>Genetic syndromes</p>
          </list-item>
          <list-item>
            <p>Environmental or teratogenic exposures&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Langerhans cell histiocytosis or other hematologic or oncologic conditions&#x000a0;<xref ref-type="bibr" rid="article-161800.r84">[84]</xref></p>
          </list-item>
          <list-item>
            <p>Nontransplacentally acquired infections</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-161800.s8" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of transplacental infections is dictated by the timing of the diagnosis and treatment and the infection severity, which can be highly variable, making studies difficult. Additionally, prognostic studies typically focus on fetal and infant outcomes; the importance of research regarding maternal outcomes following antenatal infections should not be overlooked.&#x000a0;</p>
        <p>
<bold>Syphilis</bold>
</p>
        <p>Results from a recent study conducted in the United States demonstrated a case fatality rate of congenital syphilis of 31%, primarily due to fetal demise in the third trimester.<xref ref-type="bibr" rid="article-161800.r85">[85]</xref>&#x000a0;Beyond fetal fatality, weight-for-age was lower in patients during follow-up for congenital syphilis. However, 102 of the 120 individuals studied were healthy by the last follow-up visit.<xref ref-type="bibr" rid="article-161800.r86">[86]</xref></p>
        <p>
<bold>Hepatitis C Virus</bold>
</p>
        <p>The most concerning complication of HCV infection is the development of chronic HCV, leading to liver inflammation and cirrhosis, which in turn may cause other health concerns such as hepatocellular carcinoma. Fortunately, the development of chronic infection in children with HCV infection is suspected to be much lower than in adults, with 50% to 60% of infected children developing chronic disease.<xref ref-type="bibr" rid="article-161800.r87">[87]</xref>&#x000a0;Similarly, the long-term prognosis is generally good, though interstudy variability is high. Some study results following patients after acquiring HCV at birth showed 5% to 10% of individuals with significant fibrosis and less than 5% with cirrhosis.<xref ref-type="bibr" rid="article-161800.r87">[87]</xref>&#x000a0;</p>
        <p>
<bold>Toxoplasmosis</bold>
</p>
        <p>The prospective studies that evaluated the prognosis of congenital <italic toggle="yes">T gondii</italic> infection are quite dated, and the&#x000a0;case fatality rate is difficult to determine. However, results from many studies have shown that congenital toxoplasmosis in neonates may be asymptomatic, but as many as 90% of untreated patients or 30% of treated patients may develop eye lesions that impair vision.<xref ref-type="bibr" rid="article-161800.r88">[88]</xref><xref ref-type="bibr" rid="article-161800.r89">[89]</xref><xref ref-type="bibr" rid="article-161800.r90">[90]</xref>&#x000a0;Those treated may still develop long-term ocular or other complications; available antiparasitic drugs are only active against the tachyzoite of <italic toggle="yes">T gondii</italic> and not the bradyzoite that can remain latent in the eye and nervous systems. Only 2% of those treated were suspected to have long-term neurologic sequelae.<xref ref-type="bibr" rid="article-161800.r90">[90]</xref></p>
        <p>
<bold>Listeriosis</bold>
</p>
        <p>The prognosis for pregnant individuals with listeriosis is generally good, with a study whose results revealed no deaths among 107 pregnant individuals.<xref ref-type="bibr" rid="article-161800.r27">[27]</xref>&#x000a0;However, the fetal and neonatal outcomes are much worse. A study including more than 200 pregnant individuals with listeriosis revealed that 1 in 5 pregnancies&#x000a0;end in spontaneous abortion or stillbirth, and approximately two-thirds of surviving infants develop neonatal listeriosis.<xref ref-type="bibr" rid="article-161800.r91">[91]</xref>&#x000a0;Of the 94 surviving infants, 62.8% recovered completely, 24.5% died, and 12.7% had long-term neurologic sequelae or other complications.<xref ref-type="bibr" rid="article-161800.r91">[91]</xref></p>
        <p>
<bold>Cytomegalovirus</bold>
</p>
        <p>Neonatal CMV infections have variable symptomatology, which appears predictive of outcomes. In one study, the results showed symptoms were noted in 11% of 176 CMV-infected neonates with no deaths.<xref ref-type="bibr" rid="article-161800.r92">[92]</xref>&#x000a0;At follow-up, 7% had mild, 5% moderate, and 6% severe neurological sequelae. Sequelae were more frequently noted in those symptomatic at birth (42%) than asymptomatic (14%); all moderate-to-severe outcomes included in the study were identified by age 1 year. Mild sequelae comprised some hearing loss or language developmental delay; moderate sequelae included moderate hearing loss, cerebral palsy, and moderate learning difficulties. Severe sequelae were characterized by severe disability or multiple problems. Results from studies have demonstrated some evidence that treatment with ganciclovir improves audiological outcomes in congenital CMV infection. However, the optimal duration of treatment and its long-term impact is not entirely clear.<xref ref-type="bibr" rid="article-161800.r93">[93]</xref><xref ref-type="bibr" rid="article-161800.r94">[94]</xref></p>
        <p>
<bold>Parvovirus B19</bold>
</p>
        <p>Parvovirus B19 infection is estimated to contribute 0.1% to 0.8% of the overall fetal loss burden during B19V epidemics.<xref ref-type="bibr" rid="article-161800.r95">[95]</xref>&#x000a0;Pregnant individuals with B19V infection have been found to have a 2.68 times higher risk of fetal loss, a 2.42 times higher risk of spontaneous abortion, and a 3.53 times higher risk of stillbirth compared with uninfected pregnant individuals.<xref ref-type="bibr" rid="article-161800.r96">[96]</xref>&#x000a0;Hydrops fetalis is the leading cause of fetal morbidity and mortality in B19V infections. In a study of fetal hydrops survivors, the results showed that abnormal neurodevelopment was present in 9.5% compared to 0% of the control group.<xref ref-type="bibr" rid="article-161800.r97">[97]</xref></p>
        <p>
<bold>Rubella Virus</bold>
</p>
        <p>The long-term outcomes for individuals with congenital rubella syndrome are best described by a cohort of 50 patients identified by an Australian ophthalmologist in the 1930s and 1940s.<xref ref-type="bibr" rid="article-161800.r98">[98]</xref><xref ref-type="bibr" rid="article-161800.r99">[99]</xref> In this cohort, 96% were deaf, and approximately&#x000a0;50% had typical rubella cataracts or chorioretinopathy. Other findings included mild aortic valve sclerosis (68%), diabetes (22%), thyroid disorders (19%), early menopause (73%), and osteoporosis (12.5%), all of which had a higher prevalence than the general population. Interestingly, 25% of the patients studied were found to have elevated human leukocyte antigen (HLA)-A1, HLA-B8, or HLA-DR3 antigens associated with autoimmune conditions.</p>
        <p>
<bold>Varicella Virus&#x000a0;</bold>
</p>
        <p>Congenital varicella syndrome&#x000a0;is suspected to have a mortality rate up to 30% months after birth and a 15% risk of developing zoster in the first 2 years of life. However, a good long-term outcome can occur after this initial poor prognosis stage.<xref ref-type="bibr" rid="article-161800.r35">[35]</xref><xref ref-type="bibr" rid="article-161800.r100">[100]</xref></p>
        <p>
<bold>Zika Virus</bold>
</p>
        <p>Results from a Brazilian study revealed that the mortality rate among infants with confirmed or probable congenital ZIKV infection ranged from 4% to 6%.<xref ref-type="bibr" rid="article-161800.r51">[51]</xref>&#x000a0;Another study evaluated a cohort of children presumed to have congenital ZIKV infection and the results found neurodevelopment or abnormal&#x000a0;vision or hearing assessments that were below average in 31.5% aged between 7 and 32 months.<xref ref-type="bibr" rid="article-161800.r101">[101]</xref>&#x000a0;Furthermore, the authors found that 12% scored greater than 2 standard deviations below average developmental scores in at least 1 domain, and 28% scored between 1 and 2 standard deviations below the mean in any neurodevelopmental domain assessed. Language function was most affected, with 35% below average. Predictors of improved neurodevelopmental outcomes were female sex, term delivery, normal findings on eye exams, and maternal infection at later gestational ages.</p>
      </sec>
      <sec id="article-161800.s9" sec-type="Complications">
        <title>Complications</title>
        <p>The complications arising from transplacental infections can be wide-ranging and severe, impacting the pregnant or postpartum individual and the fetus or infant. However, the complications that develop depend on the timing and severity of the specific infection, making the timely screening and management of these infections pivotal.&#x000a0;(Please refer to the <bold>Evaluation</bold> and <bold>Prognosis</bold>&#x000a0;sections for more information on infection-specific complications).</p>
      </sec>
      <sec id="article-161800.s10" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence of transplacental infections starts with comprehensive patient education on avoiding exposures that could lead to such infections.&#x000a0;(Please refer to the <bold>Etiology</bold>&#x000a0;section for more information on infection prevention.) Clinicians should emphasize the significance of regular prenatal care and follow-up, which allows for early detection and management of potential infections. Vaccination advice for preventable diseases, such as rubella and varicella, is a critical component of preconceptual counseling and care. Through proactive patient education and preventive measures, clinicians can significantly reduce the risk of transplacental infections, protecting maternal and fetal health.</p>
      </sec>
      <sec id="article-161800.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Effective management of transplacental infections necessitates a collaborative and interprofessional approach, ensuring optimal patient care and outcomes. Central to this effort is the integration of skills and expertise from a diverse healthcare team, including obstetricians, infectious disease specialists, neonatologists, nurses, pharmacists, and public health officials, among others depending on the specific infection and its known complications. Effective interprofessional communication and clear delineation of roles and responsibilities facilitate the timely exchange of vital information, alignment of management plans, and rapid response to complications, which are especially important for several reasons.</p>
        <p>Various specialists are involved in the care of pregnant or postpartum individuals and young patients (fetal or neonatal) with transplacental infections. Additionally, several care environments are involved, and perhaps different healthcare organizations are involved, considering that adult and pediatric care are utilized in managing transplacental infections. Healthcare professionals must stay abreast of evolving guidelines and recommendations to optimize patient outcomes and mitigate the impact of vertical transplacental infections on maternal and fetal health. Through a coordinated and interdisciplinary approach, healthcare teams can enhance patient-centered care, improve outcomes, ensure patient safety, and optimize team performance when managing vertical transplacental infections.&#x000a0;</p>
      </sec>
      <sec id="article-161800.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=161800&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=161800">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/vertical-transplacental-infections/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=161800">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/161800/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=161800">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-161800.s13">
        <title>References</title>
        <ref id="article-161800.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arora</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sadovsky</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dermody</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Coyne</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Microbial Vertical Transmission during Human Pregnancy.</article-title>
            <source>Cell Host Microbe</source>
            <year>2017</year>
            <month>May</month>
            <day>10</day>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>561</fpage>
            <page-range>561-567</page-range>
            <pub-id pub-id-type="pmid">28494237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Easterlin</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ramanathan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De Beritto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Maternal-to-Fetal Transmission of Syphilis and Congenital Syphilis.</article-title>
            <source>Neoreviews</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>22</volume>
            <issue>9</issue>
            <fpage>e585</fpage>
            <page-range>e585-e599</page-range>
            <pub-id pub-id-type="pmid">34470760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Benirschke</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Fetal syphilis in the first trimester.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1976</year>
            <month>Apr</month>
            <day>01</day>
            <volume>124</volume>
            <issue>7</issue>
            <fpage>705</fpage>
            <page-range>705-11</page-range>
            <pub-id pub-id-type="pmid">56895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nathan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bohman</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Leos</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Twickler</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wendel</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>In utero infection with Treponema pallidum in early pregnancy.</article-title>
            <source>Prenat Diagn</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-23</page-range>
            <pub-id pub-id-type="pmid">9061759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rac</surname>
                <given-names>MWF</given-names>
              </name>
              <name>
                <surname>Stafford</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Eppes</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Congenital syphilis: A contemporary update on an ancient disease.</article-title>
            <source>Prenat Diagn</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>13</issue>
            <fpage>1703</fpage>
            <page-range>1703-1714</page-range>
            <pub-id pub-id-type="pmid">32362058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Selke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zeh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.</article-title>
            <source>JAMA</source>
            <year>2003</year>
            <month>Jan</month>
            <day>08</day>
            <volume>289</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-9</page-range>
            <pub-id pub-id-type="pmid">12517231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auriti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Rose</surname>
                <given-names>DU</given-names>
              </name>
              <name>
                <surname>Santisi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Piersigilli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bersani</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ronchetti</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Caforio</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus.</article-title>
            <source>Biochim Biophys Acta Mol Basis Dis</source>
            <year>2021</year>
            <month>Oct</month>
            <day>01</day>
            <volume>1867</volume>
            <issue>10</issue>
            <fpage>166198</fpage>
            <pub-id pub-id-type="pmid">34118406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felker</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kaushic</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model.</article-title>
            <source>Viruses</source>
            <year>2021</year>
            <month>Sep</month>
            <day>25</day>
            <volume>13</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">34696359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bricker</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Chahroudi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.</article-title>
            <source>Front Immunol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>757400</fpage>
            <pub-id pub-id-type="pmid">34745130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sibiude</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Le Chenadec</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mandelbrot</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hoctin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dollfus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Faye</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bui</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pannier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ghosn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garrait</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Avettand-Fenoel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Frange</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Warszawski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tubiana</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.</article-title>
            <source>Clin Infect Dis</source>
            <year>2023</year>
            <month>Feb</month>
            <day>08</day>
            <volume>76</volume>
            <issue>3</issue>
            <fpage>e590</fpage>
            <page-range>e590-e598</page-range>
            <pub-id pub-id-type="pmid">36037040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>DZ</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Men</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study.</article-title>
            <source>J Med Virol</source>
            <year>2002</year>
            <month>May</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-6</page-range>
            <pub-id pub-id-type="pmid">11920813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XX</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus.</article-title>
            <source>Int J Biol Sci</source>
            <year>2015</year>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>266</fpage>
            <page-range>266-73</page-range>
            <pub-id pub-id-type="pmid">25678845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azzari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moriondo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Indolfi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Betti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gambineri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Martino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Resti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection.</article-title>
            <source>J Med Virol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-71</page-range>
            <pub-id pub-id-type="pmid">18041020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mohamoud</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Calvert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abu-Raddad</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Vertical transmission of hepatitis C virus: systematic review and meta-analysis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Sep</month>
            <day>15</day>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>765</fpage>
            <page-range>765-73</page-range>
            <pub-id pub-id-type="pmid">24928290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fauteux-Daniel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Larouche</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Calderon</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Boulais</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>B&#x000e9;land</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ransy</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Boucher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lamarre</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lapointe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boucoiran</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Le Campion</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soudeyns</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation <italic>In Utero</italic> Infection.</article-title>
            <source>J Virol</source>
            <year>2017</year>
            <month>Dec</month>
            <day>01</day>
            <volume>91</volume>
            <issue>23</issue>
            <pub-id pub-id-type="pmid">28931691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenneson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.</article-title>
            <source>Rev Med Virol</source>
            <year>2007</year>
            <season>Jul-Aug</season>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>253</fpage>
            <page-range>253-76</page-range>
            <pub-id pub-id-type="pmid">17579921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zuhair</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smit</surname>
                <given-names>GSA</given-names>
              </name>
              <name>
                <surname>Wallis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jabbar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Devleesschauwer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis.</article-title>
            <source>Rev Med Virol</source>
            <year>2019</year>
            <month>May</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>e2034</fpage>
            <pub-id pub-id-type="pmid">30706584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fowler</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Stagno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pass</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Britt</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Boll</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Alford</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.</article-title>
            <source>N Engl J Med</source>
            <year>1992</year>
            <month>Mar</month>
            <day>05</day>
            <volume>326</volume>
            <issue>10</issue>
            <fpage>663</fpage>
            <page-range>663-7</page-range>
            <pub-id pub-id-type="pmid">1310525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamoto</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Mussi-Pinhata</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Boppana</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wagatsuma</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>Pde F</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Britt</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>202</volume>
            <issue>3</issue>
            <fpage>297.e1</fpage>
            <page-range>297.e1-8</page-range>
            <pub-id pub-id-type="pmid">20060091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enders</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Daiminger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>B&#x000e4;der</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Exler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Enders</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.</article-title>
            <source>J Clin Virol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>244</fpage>
            <page-range>244-6</page-range>
            <pub-id pub-id-type="pmid">21820954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Petitt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tabata</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cytomegalovirus infection and antibody protection of the developing placenta.</article-title>
            <source>Clin Infect Dis</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>57 Suppl 4</volume>
            <issue>Suppl 4</issue>
            <fpage>S174</fpage>
            <page-range>S174-7</page-range>
            <pub-id pub-id-type="pmid">24257421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maldonado</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>JS</given-names>
              </name>
              <collab>COMMITTEE ON INFECTIOUS DISEASES</collab>
            </person-group>
            <article-title>Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States.</article-title>
            <source>Pediatrics</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>139</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28138010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hrnjakovi&#x00107;-Cvjetkovi&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jerant-Pati&#x00107;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cvjetkovi&#x00107;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mrdja</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Milosevi&#x00107;</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>[Congenital toxoplasmosis].</article-title>
            <source>Med Pregl</source>
            <year>1998</year>
            <season>Mar-Apr</season>
            <volume>51</volume>
            <issue>3-4</issue>
            <fpage>140</fpage>
            <page-range>140-5</page-range>
            <pub-id pub-id-type="pmid">9611957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charlier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Disson</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lecuit</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Maternal-neonatal listeriosis.</article-title>
            <source>Virulence</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>391</fpage>
            <page-range>391-397</page-range>
            <pub-id pub-id-type="pmid">32363991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <collab>Committee on Infectious Diseases</collab>
            <collab>Committee on Nutrition</collab>
            <collab>American Academy of Pediatrics</collab>
            <article-title>Consumption of raw or unpasteurized milk and milk products by pregnant women and children.</article-title>
            <source>Pediatrics</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>133</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-9</page-range>
            <pub-id pub-id-type="pmid">24344105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bergholz</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>den Bakker</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Fortes</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Boor</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Wiedmann</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Salt stress phenotypes in Listeria monocytogenes vary by genetic lineage and temperature.</article-title>
            <source>Foodborne Pathog Dis</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>1537</fpage>
            <page-range>1537-49</page-range>
            <pub-id pub-id-type="pmid">20707723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charlier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Perrodeau</surname>
                <given-names>&#x000c9;</given-names>
              </name>
              <name>
                <surname>Leclercq</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cazenave</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pilmis</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maury</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Moura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goffinet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dieye</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Thouvenot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ungeheuer</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Tourdjman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goulet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>de Valk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ravaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lecuit</surname>
                <given-names>M</given-names>
              </name>
              <collab>MONALISA study group</collab>
            </person-group>
            <article-title>Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2017</year>
            <month>May</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>510</fpage>
            <page-range>510-519</page-range>
            <pub-id pub-id-type="pmid">28139432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Fisher-Hoch</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Mortimer</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Human parvovirus, the cause of erythema infectiosum (fifth disease)?</article-title>
            <source>Lancet</source>
            <year>1983</year>
            <month>Jun</month>
            <day>18</day>
            <volume>1</volume>
            <issue>8338</issue>
            <fpage>1378</fpage>
            <pub-id pub-id-type="pmid">6134148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enders</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weidner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zoellner</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Searle</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Enders</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.</article-title>
            <source>Prenat Diagn</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>513</fpage>
            <page-range>513-8</page-range>
            <pub-id pub-id-type="pmid">15300741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasquinelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bonvicini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Foroni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salfi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gallinella</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Placental endothelial cells can be productively infected by Parvovirus B19.</article-title>
            <source>J Clin Virol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-8</page-range>
            <pub-id pub-id-type="pmid">19058999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ou</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Crowcroft</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2024</year>
            <month>Feb</month>
            <day>29</day>
            <volume>73</volume>
            <issue>8</issue>
            <fpage>162</fpage>
            <page-range>162-167</page-range>
            <pub-id pub-id-type="pmid">38421933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lazar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perelygina</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Martines</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paddock</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Peltecu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lupulescu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Icenogle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zaki</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome.</article-title>
            <source>EBioMedicine</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>3</volume>
            <fpage>86</fpage>
            <page-range>86-92</page-range>
            <pub-id pub-id-type="pmid">26870820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cradock-Watson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Pollock</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Consequences of confirmed maternal rubella at successive stages of pregnancy.</article-title>
            <source>Lancet</source>
            <year>1982</year>
            <month>Oct</month>
            <day>09</day>
            <volume>2</volume>
            <issue>8302</issue>
            <fpage>781</fpage>
            <page-range>781-4</page-range>
            <pub-id pub-id-type="pmid">6126663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lebo</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Kruszon-Moran</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Marin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bellini</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bialek</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>HQ</given-names>
              </name>
            </person-group>
            <article-title>Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>ofv006</fpage>
            <pub-id pub-id-type="pmid">26034757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamont</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Carrington</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mazaki-Tovi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kusanovic</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Vaisbuch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Varicella-zoster virus (chickenpox) infection in pregnancy.</article-title>
            <source>BJOG</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>118</volume>
            <issue>10</issue>
            <fpage>1155</fpage>
            <page-range>1155-62</page-range>
            <pub-id pub-id-type="pmid">21585641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Chickenpox in pregnancy: revisited.</article-title>
            <source>Reprod Toxicol</source>
            <year>2006</year>
            <month>May</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>410</fpage>
            <page-range>410-20</page-range>
            <pub-id pub-id-type="pmid">15979274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahn</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Congenital varicella syndrome: A systematic review.</article-title>
            <source>J Obstet Gynaecol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>563</fpage>
            <page-range>563-6</page-range>
            <pub-id pub-id-type="pmid">26965725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiu</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Simanjuntak</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Juan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ping</surname>
                <given-names>YH</given-names>
              </name>
            </person-group>
            <article-title>The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier.</article-title>
            <source>Front Microbiol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>214</fpage>
            <pub-id pub-id-type="pmid">32153526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moseley</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bamford</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eisen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lyall</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kingston</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pi&#x000f1;era</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rabie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kadambari</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Resurgence of congenital syphilis: new strategies against an old foe.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2024</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>e24</fpage>
            <page-range>e24-e35</page-range>
            <pub-id pub-id-type="pmid">37604180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korenromp</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Rowley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mello</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Wijesooriya</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Mahian&#x000e9;</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Newman-Owiredu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagelkerke</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kamb</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Broutet</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012.</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>e0211720</fpage>
            <pub-id pub-id-type="pmid">30811406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cejtin</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Guidry</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Boss</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Becht</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tabidze</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Notes from the Field: Diagnosis of Congenital Syphilis and Syphilis Among Females of Reproductive Age Before and During the COVID-19 Pandemic - Chicago, 2015-2022.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2023</year>
            <month>Nov</month>
            <day>24</day>
            <volume>72</volume>
            <issue>47</issue>
            <fpage>1288</fpage>
            <page-range>1288-1289</page-range>
            <pub-id pub-id-type="pmid">37991996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dubey</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Murata</surname>
                <given-names>FHA</given-names>
              </name>
              <name>
                <surname>Cerqueira-C&#x000e9;zar</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>OCH</given-names>
              </name>
              <name>
                <surname>Villena</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections.</article-title>
            <source>Parasitology</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>148</volume>
            <issue>12</issue>
            <fpage>1406</fpage>
            <page-range>1406-1416</page-range>
            <pub-id pub-id-type="pmid">34254575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Picone</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Benoist</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Binquet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kieffer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wallon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wehbe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mandelbrot</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Villena</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.</article-title>
            <source>J Gynecol Obstet Hum Reprod</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>49</volume>
            <issue>7</issue>
            <fpage>101814</fpage>
            <pub-id pub-id-type="pmid">32428782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silk</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Date</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Pouillot</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Graves</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hurd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shiferaw</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Medus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zansky</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Cronquist</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Henao</surname>
                <given-names>OL</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Vugia</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Farley</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Mahon</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>Invasive listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009: further targeted prevention needed for higher-risk groups.</article-title>
            <source>Clin Infect Dis</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>54 Suppl 5</volume>
            <fpage>S396</fpage>
            <page-range>S396-404</page-range>
            <pub-id pub-id-type="pmid">22572660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Attwood</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Identification and management of congenital parvovirus B19 infection.</article-title>
            <source>Prenat Diagn</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>13</issue>
            <fpage>1722</fpage>
            <page-range>1722-1731</page-range>
            <pub-id pub-id-type="pmid">32860469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cutts</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Diaz-Ortega</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Samuel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS.</article-title>
            <source>Bull World Health Organ</source>
            <year>1997</year>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-68</page-range>
            <pub-id pub-id-type="pmid">9141751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vynnycky</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Papadopoulos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cutts</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Hachiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miyano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reef</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019.</article-title>
            <source>Int J Infect Dis</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>137</volume>
            <fpage>149</fpage>
            <page-range>149-156</page-range>
            <pub-id pub-id-type="pmid">37690575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winter</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Rubella.</article-title>
            <source>Lancet</source>
            <year>2022</year>
            <month>Apr</month>
            <day>02</day>
            <volume>399</volume>
            <issue>10332</issue>
            <fpage>1336</fpage>
            <page-range>1336-1346</page-range>
            <pub-id pub-id-type="pmid">35367004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hills</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Zika Virus Infection.</article-title>
            <source>J Infect Dis</source>
            <year>2017</year>
            <month>Dec</month>
            <day>16</day>
            <volume>216</volume>
            <issue>suppl_10</issue>
            <fpage>S868</fpage>
            <page-range>S868-S874</page-range>
            <pub-id pub-id-type="pmid">29267914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marb&#x000e1;n-Castro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonc&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fumad&#x000f3;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Romero-Acevedo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bardaj&#x000ed;</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Zika virus infection in pregnant women and their children: A review.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>265</volume>
            <fpage>162</fpage>
            <page-range>162-168</page-range>
            <pub-id pub-id-type="pmid">34508989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fran&#x000e7;a</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Schuler-Faccini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Henriques</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Carmo</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Pedi</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Castro</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Serruya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Silveira</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Victora</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Aug</month>
            <day>27</day>
            <volume>388</volume>
            <issue>10047</issue>
            <fpage>891</fpage>
            <page-range>891-7</page-range>
            <pub-id pub-id-type="pmid">27372398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <article-title>Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>125</volume>
            <issue>6</issue>
            <fpage>1510</fpage>
            <page-range>1510-1525</page-range>
            <pub-id pub-id-type="pmid">26000539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puopolo</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Benitz</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Zaoutis</surname>
                <given-names>TE</given-names>
              </name>
              <collab>COMMITTEE ON FETUS AND NEWBORN</collab>
              <collab>COMMITTEE ON INFECTIOUS DISEASES</collab>
            </person-group>
            <article-title>Management of Neonates Born at &#x02265;35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.</article-title>
            <source>Pediatrics</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>142</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">30455342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devakumar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bamford</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Broad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rosch</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Groce</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Breuer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cardoso</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Copp</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Alexandre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Abubakar</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Infectious causes of microcephaly: epidemiology, pathogenesis, diagnosis, and management.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>e1</fpage>
            <page-range>e1-e13</page-range>
            <pub-id pub-id-type="pmid">28844634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sasidharan</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Anoop</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Congenital varicella syndrome.</article-title>
            <source>Indian J Pediatr</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-3</page-range>
            <pub-id pub-id-type="pmid">12619963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dreher</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Britt</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Boppana</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection.</article-title>
            <source>J Pediatr</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>164</volume>
            <issue>4</issue>
            <fpage>855</fpage>
            <page-range>855-9</page-range>
            <pub-id pub-id-type="pmid">24433826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Balachandran</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lonikar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Blueberry muffin baby: a pictoral differential diagnosis.</article-title>
            <source>Dermatol Online J</source>
            <year>2008</year>
            <month>Feb</month>
            <day>28</day>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">18700111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r58">
          <label>58</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Timoney</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Vail</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McGowan</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Merrick</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Radix</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <source>HIV Testing During Pregnancy, at Delivery, and Postpartum [Internet]</source>
            <publisher-name>Johns Hopkins University</publisher-name>
            <publisher-loc>Baltimore (MD)</publisher-loc>
            <year>2022</year>
            <month>09</month>
            <pub-id pub-id-type="pmid">32804447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <article-title>Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6.</article-title>
            <source>Obstet Gynecol</source>
            <year>2023</year>
            <month>Sep</month>
            <day>01</day>
            <volume>142</volume>
            <issue>3</issue>
            <fpage>745</fpage>
            <page-range>745-759</page-range>
            <pub-id pub-id-type="pmid">37590986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Curry</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kurth</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Phipps</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Screening for Syphilis Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Sep</month>
            <day>04</day>
            <volume>320</volume>
            <issue>9</issue>
            <fpage>911</fpage>
            <page-range>911-917</page-range>
            <pub-id pub-id-type="pmid">30193283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Jong</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Vossen</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Walther</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Lopriore</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>How to use... neonatal TORCH testing.</article-title>
            <source>Arch Dis Child Educ Pract Ed</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>98</volume>
            <issue>3</issue>
            <fpage>93</fpage>
            <page-range>93-8</page-range>
            <pub-id pub-id-type="pmid">23470252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fitzpatrick</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of maternal TORCH serology as a screen for suspected fetal infection.</article-title>
            <source>Prenat Diagn</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-96</page-range>
            <pub-id pub-id-type="pmid">34893980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Muzny</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Reno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zenilman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Sexually Transmitted Infections Treatment Guidelines, 2021.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2021</year>
            <month>Jul</month>
            <day>23</day>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>1</fpage>
            <page-range>1-187</page-range>
            <pub-id pub-id-type="pmid">34292926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Partridge</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bautista</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Sankaran</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Congenital Syphilis Epidemiology, Prevention, and Management in the United States: A 2022 Update.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>12</issue>
            <fpage>e33009</fpage>
            <pub-id pub-id-type="pmid">36712768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lopata</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>McNeer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dudley</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wester</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>WO</given-names>
              </name>
              <name>
                <surname>Carlucci</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Espinosa</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Dupont</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Patrick</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis C Testing Among Perinatally Exposed Infants.</article-title>
            <source>Pediatrics</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>145</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">32060140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <article-title>Committee Opinion No. 614: Management of pregnant women with presumptive exposure to Listeria monocytogenes.</article-title>
            <source>Obstet Gynecol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>1241</fpage>
            <page-range>1241-1244</page-range>
            <pub-id pub-id-type="pmid">25411758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rawlinson</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Boppana</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Kimberlin</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lazzarotto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Alain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Doutr&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Giles</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Greenlee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Palasanthiran</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schleiss</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Shand</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>van Zuylen</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>e177</fpage>
            <page-range>e177-e188</page-range>
            <pub-id pub-id-type="pmid">28291720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ald&#x000e8;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Binda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Primache</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pellegrinelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pariani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pregliasco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Di Berardino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cantarella</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ambrosetti</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Congenital Cytomegalovirus and Hearing Loss: The State of the Art.</article-title>
            <source>J Clin Med</source>
            <year>2023</year>
            <month>Jul</month>
            <day>03</day>
            <volume>12</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">37445500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <article-title>Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2001</year>
            <month>Jul</month>
            <day>13</day>
            <volume>50</volume>
            <issue>RR-12</issue>
            <fpage>1</fpage>
            <page-range>1-23</page-range>
            <pub-id pub-id-type="pmid">11475328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reef</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Plotkin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cordero</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zimmerman-Swain</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Danovaro-Holliday</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Wharton</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States.</article-title>
            <source>Clin Infect Dis</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-95</page-range>
            <pub-id pub-id-type="pmid">10913402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkalay</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pomerance</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rimoin</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Fetal varicella syndrome.</article-title>
            <source>J Pediatr</source>
            <year>1987</year>
            <month>Sep</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>320</fpage>
            <page-range>320-3</page-range>
            <pub-id pub-id-type="pmid">3625399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oduyebo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Polen</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Walke</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Reagan-Steiner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lathrop</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rabe</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Kuhnert-Tallman</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Gregory</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Ades</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perez-Padilla</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nemhauser</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Ben Beard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harcourt</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Viens</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ellington</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Reichard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Munoz-Jordan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Beach</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Barzilay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Noonan-Smith</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zaki</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Honein</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Meaney-Delman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>28</day>
            <volume>66</volume>
            <issue>29</issue>
            <fpage>781</fpage>
            <page-range>781-793</page-range>
            <pub-id pub-id-type="pmid">28749921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mercado</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ailes</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Daza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Osorio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Valencia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Galang</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ricaldi</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Kamal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Villanueva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Burkel</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Meaney-Delman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gilboa</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Honein</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Ospina</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Zika virus detection in amniotic fluid and Zika-associated birth defects.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>222</volume>
            <issue>6</issue>
            <fpage>610.e1</fpage>
            <page-range>610.e1-610.e13</page-range>
            <pub-id pub-id-type="pmid">31954155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viens</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Fleck-Derderian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baez-Santiago</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Oduyebo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Broussard</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meaney-Delman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Role of Prenatal Ultrasonography and Amniocentesis in the Diagnosis of Congenital Zika Syndrome: A Systematic Review.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>1185</fpage>
            <page-range>1185-1197</page-range>
            <pub-id pub-id-type="pmid">32282593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Barfield</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Cragan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Meaney-Delman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Staples</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peacock</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Oduyebo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Zaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>SA</given-names>
              </name>
              <collab>Contributors</collab>
            </person-group>
            <article-title>Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2016</year>
            <month>Aug</month>
            <day>26</day>
            <volume>65</volume>
            <issue>33</issue>
            <fpage>870</fpage>
            <page-range>870-878</page-range>
            <pub-id pub-id-type="pmid">27559830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <article-title>Management of Genital Herpes in Pregnancy: ACOG Practice Bulletinacog Practice Bulletin, Number 220.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>e193</fpage>
            <page-range>e193-e202</page-range>
            <pub-id pub-id-type="pmid">32332414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimberlin</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Baley</surname>
                <given-names>J</given-names>
              </name>
              <collab>Committee on infectious diseases</collab>
              <collab>Committee on fetus and newborn</collab>
            </person-group>
            <article-title>Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.</article-title>
            <source>Pediatrics</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>131</volume>
            <issue>2</issue>
            <fpage>e635</fpage>
            <page-range>e635-46</page-range>
            <pub-id pub-id-type="pmid">23359576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pantell</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Dreyer</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Kuppermann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>O'Leary</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Okechukwu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>CR</given-names>
              </name>
              <collab>SUBCOMMITTEE ON FEBRILE INFANTS</collab>
            </person-group>
            <article-title>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old.</article-title>
            <source>Pediatrics</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>148</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">34281996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choodinatha</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Cytomegalovirus infection during pregnancy.</article-title>
            <source>Obstet Gynecol Sci</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>6</issue>
            <fpage>463</fpage>
            <page-range>463-476</page-range>
            <pub-id pub-id-type="pmid">37537975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Antonio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marinceu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>436</fpage>
            <page-range>436-444</page-range>
            <pub-id pub-id-type="pmid">36484439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luck</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Wieringa</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Bl&#x000e1;zquez-Gamero</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Henneke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Capretti</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Cilleruelo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Garofoli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Iosifidis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lyall</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nieminen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pajkrt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Papaevangelou</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Posfay-Barbe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Puhakka</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roilides</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rojo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saavedra-Lozano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sharland</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saxen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vossen</surname>
                <given-names>ACTM</given-names>
              </name>
              <collab>ESPID Congenital CMV Group Meeting, Leipzig 2015</collab>
            </person-group>
            <article-title>Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>12</issue>
            <fpage>1205</fpage>
            <page-range>1205-1213</page-range>
            <pub-id pub-id-type="pmid">29140947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Updated recommendations for use of VariZIG--United States, 2013.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2013</year>
            <month>Jul</month>
            <day>19</day>
            <volume>62</volume>
            <issue>28</issue>
            <fpage>574</fpage>
            <page-range>574-6</page-range>
            <pub-id pub-id-type="pmid">23863705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernatchez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Luan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Siqueira-Neto</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Drugs for the Treatment of Zika Virus Infection.</article-title>
            <source>J Med Chem</source>
            <year>2020</year>
            <month>Jan</month>
            <day>23</day>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>470</fpage>
            <page-range>470-489</page-range>
            <pub-id pub-id-type="pmid">31549836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cyr</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Langley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Demellawy</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Ramien</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A neonate with Langerhans cell histiocytosis presenting as blueberry muffin rash: Case report and review of the literature.</article-title>
            <source>SAGE Open Med Case Rep</source>
            <year>2020</year>
            <volume>8</volume>
            <fpage>2050313X20919616</fpage>
            <pub-id pub-id-type="pmid">32547754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wozniak</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Cantey</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Zeray</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Leos</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Michelow</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Sheffield</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wendel</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>The Mortality of Congenital Syphilis.</article-title>
            <source>J Pediatr</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>263</volume>
            <fpage>113650</fpage>
            <pub-id pub-id-type="pmid">37536483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lago</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Vaccari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fiori</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and follow-up of congenital syphilis.</article-title>
            <source>Sex Transm Dis</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>85</fpage>
            <page-range>85-94</page-range>
            <pub-id pub-id-type="pmid">23324972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jhaveri</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of hepatitis C virus-infected children.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>11</issue>
            <fpage>983</fpage>
            <page-range>983-5</page-range>
            <pub-id pub-id-type="pmid">21997662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koppe</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Loewer-Sieger</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>de Roever-Bonnet</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Results of 20-year follow-up of congenital toxoplasmosis.</article-title>
            <source>Lancet</source>
            <year>1986</year>
            <month>Feb</month>
            <day>01</day>
            <volume>1</volume>
            <issue>8475</issue>
            <fpage>254</fpage>
            <page-range>254-6</page-range>
            <pub-id pub-id-type="pmid">2868264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Remington</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Stagno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.</article-title>
            <source>Pediatrics</source>
            <year>1980</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>767</fpage>
            <page-range>767-74</page-range>
            <pub-id pub-id-type="pmid">7432882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Garweg</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Abrahamowicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cornu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vinault</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quantin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonithon-Kopp</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Picot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peyron</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Binquet</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence.</article-title>
            <source>Pediatrics</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>133</volume>
            <issue>3</issue>
            <fpage>e601</fpage>
            <page-range>e601-8</page-range>
            <pub-id pub-id-type="pmid">24534412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mylonakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paliou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hohmann</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Wing</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Listeriosis during pregnancy: a case series and review of 222 cases.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>81</volume>
            <issue>4</issue>
            <fpage>260</fpage>
            <page-range>260-9</page-range>
            <pub-id pub-id-type="pmid">12169881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Townsend</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Forsgren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahlfors</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ivarsson</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Tookey</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Peckham</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom.</article-title>
            <source>Clin Infect Dis</source>
            <year>2013</year>
            <month>May</month>
            <volume>56</volume>
            <issue>9</issue>
            <fpage>1232</fpage>
            <page-range>1232-9</page-range>
            <pub-id pub-id-type="pmid">23334811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lanzieri</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Caviness</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Demmler-Harrison</surname>
                <given-names>G</given-names>
              </name>
              <collab>Congenital Cytomegalovirus Longitudinal Study Group</collab>
            </person-group>
            <article-title>Progressive, Long-Term Hearing Loss in Congenital CMV Disease After Ganciclovir Therapy.</article-title>
            <source>J Pediatric Infect Dis Soc</source>
            <year>2022</year>
            <month>Jan</month>
            <day>27</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-23</page-range>
            <pub-id pub-id-type="pmid">34718680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimberlin</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Jester</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arav-Boger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Michaels</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Ashouri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Englund</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Estrada</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Sood</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Whitworth</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Abzug</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Caserta</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lujan-Zilbermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Storch</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>DeBiasi</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Bocchini</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dennehy</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Finn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Luck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gutierrez</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Halasa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Homans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shane</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Sharland</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simonsen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vanchiere</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Sabo</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Aban</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Prichard</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giles</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Acosta</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Whitley</surname>
                <given-names>RJ</given-names>
              </name>
              <collab>National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group</collab>
            </person-group>
            <article-title>Valganciclovir for symptomatic congenital cytomegalovirus disease.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>05</day>
            <volume>372</volume>
            <issue>10</issue>
            <fpage>933</fpage>
            <page-range>933-43</page-range>
            <pub-id pub-id-type="pmid">25738669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lassen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bager</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Panum</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>N&#x000f8;rgaard-Pedersen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aaby</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wohlfahrt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Melbye</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study.</article-title>
            <source>Am J Epidemiol</source>
            <year>2012</year>
            <month>Nov</month>
            <day>01</day>
            <volume>176</volume>
            <issue>9</issue>
            <fpage>803</fpage>
            <page-range>803-7</page-range>
            <pub-id pub-id-type="pmid">23051601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiong</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis.</article-title>
            <source>J Clin Virol</source>
            <year>2019</year>
            <month>May</month>
            <volume>114</volume>
            <fpage>12</fpage>
            <page-range>12-20</page-range>
            <pub-id pub-id-type="pmid">30897374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bascietto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Liberati</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murgano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Buca</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Iacovelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Flacco</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Manzoli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Familiari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scambia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>D'Antonio</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>569</fpage>
            <page-range>569-576</page-range>
            <pub-id pub-id-type="pmid">29785793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forrest</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Turnbull</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Sholler</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Hawker</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Doran</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Gregg's congenital rubella patients 60 years later.</article-title>
            <source>Med J Aust</source>
            <year>2002</year>
            <month>Dec</month>
            <day>2-16</day>
            <volume>177</volume>
            <issue>11-12</issue>
            <fpage>664</fpage>
            <page-range>664-7</page-range>
            <pub-id pub-id-type="pmid">12463994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McIntosh</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Menser</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>A fifty-year follow-up of congenital rubella.</article-title>
            <source>Lancet</source>
            <year>1992</year>
            <month>Aug</month>
            <day>15</day>
            <volume>340</volume>
            <issue>8816</issue>
            <fpage>414</fpage>
            <page-range>414-5</page-range>
            <pub-id pub-id-type="pmid">1353568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schulze</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dietzsch</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>The natural history of varicella embryopathy: a 25-year follow-up.</article-title>
            <source>J Pediatr</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>137</volume>
            <issue>6</issue>
            <fpage>871</fpage>
            <page-range>871-4</page-range>
            <pub-id pub-id-type="pmid">11113846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161800.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nielsen-Saines</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brasil</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kerin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vasconcelos</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gabaglia</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Damasceno</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abreu de Carvalho</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Pone</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Zin</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Tsui</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Salles</surname>
                <given-names>TRS</given-names>
              </name>
              <name>
                <surname>da Cunha</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Malacarne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Hasue</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Aizawa</surname>
                <given-names>CYP</given-names>
              </name>
              <name>
                <surname>Genovesi</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Einspieler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marschik</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gaw</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cherry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moreira</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children.</article-title>
            <source>Nat Med</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>8</issue>
            <fpage>1213</fpage>
            <page-range>1213-1217</page-range>
            <pub-id pub-id-type="pmid">31285631</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
